Clinical trial
Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa
NCT00904163 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa
- Lead sponsor
- Stanford University
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2009
- Completion date
- May 31, 2014
- Enrollment
- 13 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.